Sage Journals: Discover world-class research

Open access

Review article

First published 2020

Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies

Theodoros P. Vassilakopoulos, John V. Asimakopoulos, Kostas Konstantopoulos [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2020

Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series

Helen Ma, Bin Cheng, Francesca Montanari [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2020-12

The effect of gemcitabine,dexamethasone,and cisplatin chemotherapy in relapsed/refractory NHL and HL patients: A single center experience

Hikmettullah Batgi, Alparslan Merdin, Mehmet Sinan Dal [...]

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2016-4

Obinutuzumab for relapsed or refractory indolent non-Hodgkin’s lymphomas

Ludovic Gabellier, Guillaume Cartron

Therapeutic Advances in Hematology

Open access

Review article

First published 2012

Emerging Pharmacotherapy for Relapsed or Refractory Hodgkins Lymphoma: Focus on Brentuximab Vedotin

Michelle Furtado, Simon Rule

Clinical Medicine Insights: Oncology

Retricted access

Research article

First published 2018-12

High-dose chemotherapy and peripheral hematopoietic stem cell transplantation in relapsed/refractory Hodgkin’s lymphoma

Mouhammed Kelta, Jamal Zekri, Ehab Abdelghany [...]

Tumori Journal

Free access

Review article

First published 2018-4

Pembrolizumab and its role in relapsed/refractory classical Hodgkin’s lymphoma: evidence to date and clinical utility

Polina Shindiapina, Lapo Alinari

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2012-11

Iodine-131 Rituximab Radioimmunotherapy with BEAM Conditioning and Autologous Stem Cell Transplant Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Paul C. Kruger, Julian P. Cooney, J. Harvey Turner

Cancer Biotherapy and Radiopharmaceuticals

Open access

Research article

First published 2020

Comparison of Survival Between Autologous and Allogeneic Stem Cell Transplantation in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Meta-Analysis

Jianhong Wang, Xiaohui Duan, Lijie Yang [...]

Cell Transplantation

Open access

Research article

First published 2025

Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia

Jean-Marie Michot, Zsofia Balogh, Jennifer R. Brown [...]

Therapeutic Advances in Drug Safety

Search results